Inc. (NASDAQ: STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from neurohealth disorders, today ...

Reductions also seen in comorbid anxiety and depression symptomsBURLINGTON, Mass. and JERUSALEM, Israel, Nov. 20, 2024 (GLOBE NEWSWIRE) -- Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a ...

TMS, and fNIRS. - Neuroplasticity and Neurocognition in Rehabilitation: Research on rehabilitation protocols that leverage neuroplasticity and neurocognition to enhance recovery (e.g., proprioceptive ...

EDAP TMS (EDAP) announced a moderated scientific presentation of clinical data comparing Focal One HIFU versus surgery for the treatment of ...

Industry veteran with extensive experience in key areas of focus Interim-CFO Richard Narido to focus on HOPE Therapeutics acquisition opportunities WILMINGTON, Del., Nov. 18, 2024 ...

The NBS System 5 is the only FDA cleared and CE marked navigated TMS system for presurgical mapping of the speech and motor cortices of the brain. Nexstim’s Therapy Business markets and sells the NBS ...

These preclinical findings could lead ... Single-Dose Gene Therapy Is Potentially Life-Changing for Adults With Hemophilia B Sep. 25, 2024 — Adults with hemophilia B saw their number of bleeding ...

Greenbrook TMS Inc. ("Greenbrook" or the "Company") is pleased to announce that the Company has obtained a final order from the Ontario Superior Court of Justice (Commercial List) approving the ...

Mental health is a vital aspect of overall well-being, especially for students who face unique pressures and challenges. From ...

Palvelussamme on juuri nyt häiriö, yritäthän myöhemmin uudelleen. Pahoittelemme aiheutunutta haittaa.

hyperbaric oxygen therapy (HBOT), transcatheter aortic valve replacement (TAVR), and transcranial magnetic stimulation (TMS) ...